Antivirals TRIZ Cases
- Inhibiting RNA-Binding Proteins to Enhance CTL Activation
Inhibiting ZFP36 and ZFP36L1 boosts effector cytokine production, resolving limited CTL efficacy in cancer therapy.
Inhibiting ZFP36 and ZFP36L1 boosts effector cytokine production, resolving limited CTL efficacy in cancer therapy.